신약개발을 위한 임상연구간호사의 역할수행과 관련 요인

• 영문명: Role Performance and Related Factors of Clinical Research Nurses in New Drug Development
• 발행기관: 한국기초간호학회
• 저자명: 박재은(Park Jeaeun) 김신미(Kim Shinmi)
• 간행물 정보: 『Journal of Korean Biological Nursing Science』제22권 제3호, 213~221쪽, 전체 9쪽
• 주제분류: 의약학 > 의학일반
• 파일형태: PDF
• 발행일자: 2020.08.31

영문 초록

The purpose of this study was to explore the role performance and related factors of clinical research nurses (CRN) in the process of clinical trials of new drug development. Methods: Study participants were CRN whose affiliation was in non-capital areas and who had been working longer than three months at the time of the data collection. The data collection was conducted with a semi-structured questionnaire development by Hwang & Go, 2011 comprising 16 items of participants’ characteristics and 60 items of role performance via in-person and online. Additionally, opinions which would be necessary to establish the CRN role were questioned for the future. A total of 141 questionnaires of 151 questionnaires responses were analyzed using descriptive statistics, t-test, and ANOVA for data analysis as appropriate. Results: The level of overall role performance was above average (5.61±0.90) with the highest in subject care (6.04±0.96) and management and the lowest in self-development (4.39±1.52). The only factor affecting overall role performance was employment status and the only sub-category affected by factors of employment status, and some general characteristics was self-development. Conclusion: From study results, it can be concluded that the CRN seem to perform their proper role. Nonetheless, self-development should be considered as critical aspect for better CRN competency, which is an important aspect toward improving the CRN role performance. Additionally, efforts to improve the level of role performance must be established through stable employment and concrete departmental placement as suggested in this study.

목차

서 론

연구 방법

연구 결과

논 의

결 론

키워드

임상 연구 간호사 임상시험 신약개발 역할수행 Nurse’s role Clinical trial Drug development